Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

Similar articles for PubMed (Select 18307785)

1.

The United States and Canada as a coupled epidemiological system: an example from hepatitis A.

Amariei R, Willms AR, Bauch CT.

BMC Infect Dis. 2008 Feb 28;8:23. doi: 10.1186/1471-2334-8-23.

2.

Hepatitis A vaccination coverage among adults 18-49 years traveling to a country of high or intermediate endemicity, United States.

Lu PJ, Byrd KK, Murphy TV.

Vaccine. 2013 May 1;31(19):2348-57. doi: 10.1016/j.vaccine.2013.03.011. Epub 2013 Mar 21.

PMID:
23523408
3.

Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A.

Srinivasa Rao AS, Chen MH, Pham BZ, Tricco AC, Gilca V, Duval B, Krahn MD, Bauch CT.

BMC Infect Dis. 2006 Dec 5;6:174.

4.

Surveillance for acute viral hepatitis - United States, 2007.

Daniels D, Grytdal S, Wasley A; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2009 May 22;58(3):1-27.

5.

Surveillance for acute viral hepatitis--United States, 2006.

Wasley A, Grytdal S, Gallagher K; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2008 Mar 21;57(2):1-24.

6.
7.

Nationwide canadian study of hepatitis a antibody prevalence among children eight to thirteen years old.

Duval B, De Serres G, Ochnio J, Scheifele D, Gîlca V.

Pediatr Infect Dis J. 2005 Jun;24(6):514-9.

PMID:
15933561
8.

A mathematical model of hepatitis a transmission in the United States indicates value of universal childhood immunization.

Van Effelterre TP, Zink TK, Hoet BJ, Hausdorff WP, Rosenthal P.

Clin Infect Dis. 2006 Jul 15;43(2):158-64. Epub 2006 Jun 12.

9.

A dynamic model for assessing universal Hepatitis A vaccination in Canada.

Bauch CT, Rao AS, Pham BZ, Krahn M, Gilca V, Duval B, Chen MH, Tricco AC.

Vaccine. 2007 Feb 26;25(10):1719-26. Epub 2006 Nov 27.

PMID:
17229493
10.

Hepatitis A risk in travelers.

Askling HH, Rombo L, Andersson Y, Martin S, Ekdahl K.

J Travel Med. 2009 Jul-Aug;16(4):233-8. doi: 10.1111/j.1708-8305.2009.00307.x. Erratum in: J Travel Med. 2009 Nov-Dec;16(6):412.

PMID:
19674261
11.

Cost-utility of universal hepatitis A vaccination in Canada.

Bauch CT, Anonychuk AM, Pham BZ, Gilca V, Duval B, Krahn MD.

Vaccine. 2007 Dec 12;25(51):8536-48. Epub 2007 Oct 23.

PMID:
17996339
13.

Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.

Sartori AM, de Soárez PC, Novaes HM, Amaku M, de Azevedo RS, Moreira RC, Pereira LM, Ximenes RA, Martelli CM.

Vaccine. 2012 Dec 14;30(52):7489-97. doi: 10.1016/j.vaccine.2012.10.056. Epub 2012 Oct 27.

14.

Regional variation in the cost effectiveness of childhood hepatitis A immunization.

Jacobs RJ, Greenberg DP, Koff RS, Saab S, Meyerhoff AS.

Pediatr Infect Dis J. 2003 Oct;22(10):904-14.

PMID:
14551492
15.

Hepatitis A virus infections in travelers, 1988-2004.

Mutsch M, Spicher VM, Gut C, Steffen R.

Clin Infect Dis. 2006 Feb 15;42(4):490-7. Epub 2006 Jan 11.

16.

Use of a catalytic model to estimate hepatitis A incidence in a low-endemicity country: implications for modeling immunization policies.

Pham B, Chen MH, Tricco AC, Anonychuk A, Krahn M, Bauch CT.

Med Decis Making. 2012 Jan-Feb;32(1):167-75. doi: 10.1177/0272989X11398489. Epub 2011 Mar 10.

PMID:
21393559
17.

The changing epidemiology of hepatitis A in Arizona following intensive immunization programs (1988-2007).

Erhart LM, Ernst KC.

Vaccine. 2012 Sep 14;30(42):6103-10. doi: 10.1016/j.vaccine.2012.07.029. Epub 2012 Jul 24.

PMID:
22835739
18.

A nationwide survey of past hepatitis A infections among Canadian adults.

Scheifele DW, De Serres G, Gilca V, Duval B, Milner R, Ho M, Ochnio JJ.

Vaccine. 2010 Jul 19;28(32):5174-8. doi: 10.1016/j.vaccine.2010.05.076. Epub 2010 Jun 15.

PMID:
20558251
19.

Hepatitis A, typhoid and malaria among travelers--surveillance data from Québec (Canada).

Provost S, Gagnon S, Lonergan G, Bui YG, Labbé AC.

J Travel Med. 2006 Jul-Aug;13(4):219-26.

PMID:
16884404
20.

Model-based projections of the population-level impact of hepatitis A vaccination in Mexico.

Van Effelterre T, De Antonio-Suarez R, Cassidy A, Romano-Mazzotti L, Marano C.

Hum Vaccin Immunother. 2012 Aug;8(8):1099-108. doi: 10.4161/hv.20549. Epub 2012 Aug 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk